ライフサイエンスコーパス: inclusion criteria

1 20 unique studies with 224 patients met the inclusion criteria.

2 studies, mainly involving dentists, met the inclusion criteria.

3 assays, and 5 of tTG and EMA assays) met our inclusion criteria.

4 ndently screened articles for fulfillment of inclusion criteria.

5 Nine hundred five cases met the inclusion criteria.

6 ue articles were identified, of which 23 met inclusion criteria.

7 published between 1980 and 2014 that met our inclusion criteria.

8 Three-hundred seventeen patients met inclusion criteria.

9 Results Six hundred fifty-three men met the inclusion criteria.

10 se-control studies comprising 15 samples met inclusion criteria.

11 udies (1049 children, 10 057 adults) met the inclusion criteria.

12 A total of 44 eyes met the inclusion criteria.

13 Of the 518 articles found, 49 met the inclusion criteria.

14 174,097 children without) from 1929-2015 met inclusion criteria.

15 s at the participating centers; 2300 met our inclusion criteria.

16 ssessed the relevance of papers based on the inclusion criteria.

17 Twenty-three studies satisfied our inclusion criteria.

18 d trials and 3 observational studies met the inclusion criteria.

19 exclusion using a priori criteria; 3.9% met inclusion criteria.

20 ts underwent cataract surgery and 89 731 met inclusion criteria.

21 yielded 10 studies, of which only 1 met the inclusion criteria.

22 andomized controlled trials (n=4666) met our inclusion criteria.

23 A total of 31 patients met inclusion criteria.

24 eligible studies; of which, 17 satisfied our inclusion criteria.

25 included on the basis of refractory disease inclusion criteria.

26 w's milk studies fulfilled our pre-specified inclusion criteria.

27 for (18)F-FDG PET-CT and 2 for LS), met the inclusion criteria.

28 A total of 57,988 patients met inclusion criteria.

29 ) with a total of 29822 participants met the inclusion criteria.

30 patients (1911 PSP, 4282 MSA) fulfilled the inclusion criteria.

31 A total of 106 articles satisfied the inclusion criteria.

32 Results Twenty studies met the inclusion criteria.

33 age of 78.87 years (range, 56-96 years) met inclusion criteria.

34 Ten studies that examined NCFs fulfilled inclusion criteria.

35 ses summarizing 1458 primary studies met the inclusion criteria.

36 Twenty-one trials and 756 pregnancies met inclusion criteria.

37 Twenty-six articles met the inclusion criteria.

38 Eighty-two patients fulfilled the inclusion criteria.

39 In total, 604 of 2607 trials retrieved met inclusion criteria.

40 identified 5 randomized trials that met our inclusion criteria.

41 hes were conducted on articles meeting study inclusion criteria.

42 artile range] age, 65 [55-72] years) met the inclusion criteria.

43 and HCV or TBV, and 46 studies fulfilled the inclusion criteria.

44 , and 9 studies including 27630 patients met inclusion criteria.

45 f age, from a neighbouring household who met inclusion criteria.

46 CIS were screened, of whom 368 met all study inclusion criteria.

47 ologic condition.Thirty-four studies met the inclusion criteria.

48 Twenty-seven patients (13 men) met our inclusion criteria.

49 s were identified, of which 40 fulfilled the inclusion criteria.

50 PET or (18)F-FDG PET/CT examinations met our inclusion criteria.

51 370), 8 in adults and 4 in children, met the inclusion criteria.

52 eriod, and 11 patients (15 malignancies) met inclusion criteria.

53 c transition in the study period, 33 met our inclusion criteria.

54 We identified 37 studies meeting these inclusion criteria.

55 PET or (18)F-FDG PET/CT examinations met our inclusion criteria.

56 Sixty-one studies met the inclusion criteria.

57 Sixteen papers met the inclusion criteria.

58 Only 37 articles from 373 citations met our inclusion criteria.

59 es, and 1 retrospective cohort study met the inclusion criteria.

60 identified 330 articles, of which 61 met the inclusion criteria.

61 articles, eight (reporting six studies) met inclusion criteria.

62 Ninety-five eyes met the inclusion criteria.

63 374 patients included in the study, 353 met inclusion criteria.

64 for the study, 935 individuals fulfilled the inclusion criteria.

65 ight studies (reported in 11 papers) met the inclusion criteria.

66 quarter and 972 in the final quarter who met inclusion criteria.

67 Two hundred one patients met inclusion criteria.

68 ministrations of 23.4% hypertonic saline met inclusion criteria.

69 Three hundred sixteen patients met the inclusion criteria.

70 tations, 20 primary studies met prespecified inclusion criteria.

71 rporeal membrane oxygenator patients met the inclusion criteria.

72 eports from 1880 through 2013 met predefined inclusion criteria.

73 f 661 patients with HPV-positive OPC met the inclusion criteria.

74 total of 208 identified publications, 28 met inclusion criteria.

75 1387 small HCC lesions in 1908 patients met inclusion criteria.

76 arch found 2996 studies, of which 26 met the inclusion criteria.

77 ed, 24 studies (16 565 participants) met the inclusion criteria.

78 Seventeen eyes of 17 patients met inclusion criteria.

79 37 studies met our inclusion criteria.

80 6626 abstracts, of which 50 articles met the inclusion criteria.

81 s study quality; however, no studies met the inclusion criteria.

82 One hundred thirty-seven patients met the inclusion criteria.

83 tudies, 29 (5,473 patients) of which met the inclusion criteria.

84 o Avila-Ortiz et al. (2013), only 52 met the inclusion criteria.

85 e of 38.8 [9.2] years at enrollment) met the inclusion criteria.

86 IM Dysplasia trial, 119 received RFA and met inclusion criteria.

87 all, 6303 patients with 8711 encounters met inclusion criteria.

88 tudies, representing 20892 patients, met all inclusion criteria.

89 om alerts and hand searches; 238 studies met inclusion criteria.

90 ed upon restriction to men meeting strict AS inclusion criteria.

91 ildren (aged <18 years), 27 children met the inclusion criteria.

92 We abstracted data from 21 articles that met inclusion criteria.

93 e and 3394 Medicaid recipients met the study inclusion criteria.

94 systematic review and 3 primary studies met inclusion criteria.

95 232 studies met the inclusion criteria.

96 A total of 483 patients met the inclusion criteria.

97 and 2 evidence-based clinical guidelines met inclusion criteria.

98 r hundred and seventy-eight subjects met our inclusion criteria.

99 rall, 206 implants in 115 patients fulfilled inclusion criteria.

100 Thirteen studies met the inclusion criteria.

101 Eighty-six cases met strict inclusion criteria.

102 dies for (67)Ga citrate scintigraphy met the inclusion criteria.

103 In all, 2413 patients met the inclusion criteria.

104 le abstracts and full texts against a priori inclusion criteria.

105 atic reviews and 28 reports of 27 trials met inclusion criteria.

106 Of 28 636 articles screened, 3396 met inclusion criteria.

107 cardial infarction (STEMI) has no biological inclusion criteria.

108 ed eighteen patients were identified who met inclusion criteria.

109 BASE, we identified 61 articles that met the inclusion criteria.

110 with a total of 29822 participants) met the inclusion criteria.

111 dy period, of which 32 (27 patients) met the inclusion criteria.

112 Forty-one studies (N=30 773) met inclusion criteria.

113 Six studies met the inclusion criteria.

114 Fifteen studies met the inclusion criteria; 10 studies met the criteria for inte

115 Twenty-eight studies met the inclusion criteria, 12 on cancer, nine on cardiovascular

116 A total of 331 patients met inclusion criteria; 12% were underweight, 50% normal wei

117 Overall, 8,112 offspring met the inclusion criteria; 13.6% had a parental hip fracture di

118 Among the 4616 patients who fulfilled our inclusion criteria (1351 everolimus-eluting stent and 32

119 Forty-six studies met the inclusion criteria (18 schizophrenia, 16 bipolar disorde

120 Results: Of the 234 patients who met inclusion criteria, 191 (81.6%) were male, and the media

121 Twenty-four studies met the inclusion criteria; 20 studies were included in the meta

122 Of 1,685 patients meeting inclusion criteria, 210 (12.5%) were on statin therapy p

123 Of the 6767 patients who met the inclusion criteria, 2429 were included in the analysis (

124 In all, 59,734 patients met inclusion criteria; 2687 (4.5%) experienced an unplanned

125 All subjects met national IBD surveillance inclusion criteria; 27 were assigned randomly to groups

126 Of 36 405 patients who met inclusion criteria, 34 200 (94%) initially received intr

127 Of the 659357 enrollees who met inclusion criteria (391674 females and 267683 males; mea

128 Among the 86 patients who met inclusion criteria (49 men [57%]; 37 women [43%]; mean [

129 Of 3805 publications retrieved, 42 met inclusion criteria (5 randomized controlled trials and 3

130 mean [SD] age, 40.0 [5.3] years) who met the inclusion criteria, 5267 (68.5%) had no previous cesarea

131 We identified 68 publications meeting inclusion criteria: 59 reporting the prevalence of preop

132 creening 2292 citations, 43 articles met our inclusion criteria (61 unique cohorts; n>11,374 fistulas

133 Results Overall, 14,554 patients met inclusion criteria (7,906 N0 patients; 6,648 node-positi

134 Of the 180 patients who met inclusion criteria, 77 used bifocals and 103 used single

135 llennium Cohort study at 3 years who met our inclusion criteria, 844 (14%) had a new transition into

136 ligibility was mostly due to failure to meet inclusion criteria (87% of screening assessments) rather

137 Of 715 patients meeting the inclusion criteria, 88 patients were enrolled and receiv

138 from 157 countries (2207 datapoints) met the inclusion criteria, a 90% increase from 2009 estimates.

139 Of the 1667 participants who fulfilled the inclusion criteria, all cases with AN (n = 216) and 300

140 Inclusion criteria allowed enrollment of patients with r

141 for eligibility, of whom 84 did not meet the inclusion criteria and 21 declined to participate.

142 h pediatric acute liver failure, 136 met the inclusion criteria and 45 of these received continuous r

143 lastoma and HRPFs used prospectively defined inclusion criteria and a sampling strategy to procure bo

144 nt mandibular incisors, fulfilling necessary inclusion criteria and aged 18 to 60 years were evaluate

145 es, conducted between 1949 and 2007, met the inclusion criteria and contributed 42 data sets and 12,8

146 Of 7065 reports identified, 184 met inclusion criteria and described 360 pediatric botulism

147 selecting papers for review according to the inclusion criteria and extracting information on study c

148 Patients not fulfilling all inclusion criteria and having MRIs with poor quality or

149 Fifty-eight adult patients met the inclusion criteria and participated in the study.

150 s opened by 254 recipients, with 186 meeting inclusion criteria and providing data about the region i

151 Fifteen studies met inclusion criteria and quality appraisal guidelines, how

152 essed in all randomised patients who met the inclusion criteria and received at least one dose of stu

153 A total of 493 carriers met the inclusion criteria and were analyzed.

154 al between August 2008 and June 2015 met the inclusion criteria and were evaluated in this study.

155 terior circulation infarction) fulfilled the inclusion criteria and were included in the analyses.

156 A total of 48 studies met the inclusion criteria and were included in the review.

157 dies published between 2010 and 2016 met the inclusion criteria and were pooled for analysis.

158 s consented to study enrollment, 380 met the inclusion criteria and were randomized.

159 1334 patients met inclusion criteria and were randomly assigned to treatme

160 records (comprising 20,306 participants) met inclusion criteria and were taken through to data collec

161 e diversity of the study population based on inclusion criteria and/or the absence of uniformly large

162 s identified, 247 full-text articles met our inclusion criteria, and 124 provided data for surgical m

163 Results Three hundred reviews met the inclusion criteria, and in 118 (39%) of those, authors u

164 Three trials met our inclusion criteria, and included 413 patients with type

165 udies, 766 were evaluated against full study inclusion criteria, and we acquired full text for 8.

166 Twenty-three did not meet inclusion criteria, chose to withdraw, or had a change i

167 studies published between 2000 and 2014 met inclusion criteria, collectively enrolling 17,387 cases

168 yielded 6959 unique studies, of which 9 met inclusion criteria (comprising 17389 adolescents and you

169 We identified 4339 studies, 68 of which met inclusion criteria, comprising 24 456 adults and 809 chi

170 Inclusion criteria consisted of a confirmed diagnosis of

171 Inclusion criteria consisted of a randomized clinical tr

172 Inclusion criteria consisted of CRF severity as an outco

173 Inclusion criteria consisted of original studies that as

174 2012, through December 31, 2013, who met the inclusion criteria (database cohort).

175 s were transferred, only 70 patients met the inclusion criteria during the study period.

176 5,553,984 patients in the CPRD that met our inclusion criteria, during the 10-year follow-up period,

177 Based on inclusion criteria (English-language published qualitati

178 cluded only English-language studies, narrow inclusion criteria focused only on MDD, high thresholds

179 8 (6.1%), 274 (8.0%), and 318 (9.3%) met the inclusion criteria for analysis of MMR, IG, and any PEP

180 Inclusion criteria for DMT stoppers were: age >/=18 year

181 ple primary MCC were identified; 4 cases met inclusion criteria for next-generation sequencing (NGS)

182 3,188 citations reviewed, 10 studies met the inclusion criteria for systematic review, including a to

183 3188 citations reviewed, 10 studies met the inclusion criteria for systematic review, including a to

184 Fourteen articles met eligibility and inclusion criteria for systematic review; they included

185 Seventy-three studies met the inclusion criteria for the meta-analysis.

186 d through search methods, 17 studies met the inclusion criteria for the review.

187 ant NSCLC developed brain metastases and met inclusion criteria for the study.

188 Inclusion criteria for this analysis were SPIROMICS base

189 Inclusion criteria for this prospective diagnostic study

190 There were six eligible studies that met the inclusion criteria, for a total of 4,385 acute ICH patie

191 With less stringent inclusion criteria (i.e., >/=85% of an axon's varicose b

192 requently are not curated or have permissive inclusion criteria, impairing their use.

193 Scores were all applied to patients meeting inclusion criteria in both cohorts, and their area under

194 Inclusion criteria included a GOG performance status sco

195 Inclusion criteria included a Positive and Negative Synd

196 Inclusion criteria included a positive skin prick test o

197 Inclusion criteria included nurses registered with the N

198 Inclusion criteria included patient number >15, report o

199 f reproductive age (WRA).The BRINDA database inclusion criteria included surveys that 1) were conduct

200 Inclusion criteria included: (1) registered nurses pract

201 Six observational studies met inclusion criteria including 41,910 women who received f

202 We identified 3881 records, of which 41 met inclusion criteria, including 1403 adult patients and 19

203 patients were exposed; 21 395 (69%) met all inclusion criteria, including 4916 in the reference grou

204 Seven studies met the inclusion criteria, including 833 stable patients (1377

205 ICH were screened, and 2103 patients met the inclusion criteria (mean [SD] age, 72.7 [12.5] years; 54

206 the symptoms of asthma; used a single set of inclusion criteria; measured FE NO50 in accordance with

207 Five randomized clinical trials met our inclusion criteria (n = 1287 patients).

208 Overall, 29.9% of patients meeting the inclusion criteria (n = 4235) were eligible for step dow

209 81 infants were excluded for not meeting the inclusion criteria (n=50) or for other reasons (n=31).

210 15 individuals aged 50-65-year fulfilled the inclusion criteria (NAFLD with impaired fasting glucose

211 18 patients were excluded due to inclusion criteria not met (six patients), declined to p

212 who were assessed, 398 (30.7%) fulfilled the inclusion criteria of 5 or more VFs and 5 years or more

213 tabolic control may be relevant for refining inclusion criteria of clinical trials in the settings of

214 who had been followed up to autopsy and met inclusion criteria of Lewy body disorder with autopsy-co

215 with minimal comorbid conditions meeting the inclusion criteria of the NLST who underwent surgery had

216 to 50% of IR patients do not meet the strict inclusion criteria of the trials conducted so far.

217 In addition to the inclusion criteria of these trials, our study necessitat

218 32% of patients with FMS met the inclusion criteria, of which 90% enrolled.

219 A total of 112 submitted applications met inclusion criteria; of these, 40 (35.7%) were funded, an

220 Thirty-nine articles fulfilled the inclusion criteria; one study was excluded from the anal

221 INCLUSION CRITERIA: participants with primary or seconda

222 18 of 1075 articles reviewed met inclusion criteria, providing data from 67 451 invasive

223 We identified 235 articles that met the inclusion criteria, published between 1923 and 2016.

224 A total of 18 papers met the inclusion criteria, reporting results from 15 study popu

225 elected for full-text review, and 29 met the inclusion criteria, representing 10430 patients from 11

226 r reviewing 4242 records, 75 studies met our inclusion criteria, representing 2 135 314 individuals o

227 Inclusion criteria required participants to be at least

228 67 citations identified, 783 studies met the inclusion criteria, resulting in 902 estimates of the pr

229 or estimating clinical efficacy of drugs and inclusion criteria screening.

230 ics and oral implantology purposes using the inclusion criteria selected in this study.

231 This was at least in part due to different inclusion criteria, self-monitoring regimes, and target

232 In the present trial, which allowed broad inclusion criteria, the novel RESs met the prespecified

233 Few studies met inclusion criteria, therefore results should be cautious

234 und challenge because they no longer met the inclusion criteria; these participants were excluded fro

235 easures: This study adopted relatively broad inclusion criteria to achieve a quantitative measure of

236 Twelve total references met the inclusion criteria to determine the role of CBCT in diag

237 We applied broad inclusion criteria to maximize data inputs, particularly

238 ast 3 years in patients without BCR were the inclusion criteria to select 77 patients out of the 874

239 e proportion of cases meeting all ProPublica inclusion criteria was determined.

240 Of 4979 patients who met inclusion criteria, we identified 867 Local patients who

241 The inclusion criteria were (1) pediatric seizure onset with

242 Inclusion criteria were (i) patients with rheumatoid art

243 Inclusion criteria were 1) RCT, 2) subjects aged >/=19 y

244 Key inclusion criteria were a diagnosis of definite relapsin

245 Inclusion criteria were a study population 40 years of a

246 Other inclusion criteria were a WHO performance status of 0-2,

247 Inclusion criteria were adapted from National Institutes

248 Inclusion criteria were admission to a participating int

249 The inclusion criteria were adult patients incident in PD.

250 Key inclusion criteria were age 25-65 years, clinical diagno

251 Inclusion criteria were age of 18 years or older and wil

252 Inclusion criteria were amended on Feb 25, 2010, to incl

253 Inclusion criteria were an Eastern Cooperative Oncology

254 Inclusion criteria were as follows: (1) AQP4-IgG seropos

255 The inclusion criteria were as follows: randomized control t

256 Inclusion criteria were based on the Sampson criteria of

257 Inclusion criteria were CE-MRI within 30 d and pathology

258 Among the 15 trials, the most common trial inclusion criteria were clinical criteria for sepsis (si

259 The inclusion criteria were clinically suspected IE and ICED

260 Inclusion criteria were COPD exacerbations with PaCO2 >/

261 " "Periotest," "Periotest value," and "PTV." Inclusion criteria were English language, prospective, r

262 Sixty-two articles not meeting inclusion criteria were further excluded.

263 Children who met the study inclusion criteria were identified from the Medicaid Ana

264 From 2002 to 2015, 31 articles meeting the inclusion criteria were identified in the literature.

265 Inclusion criteria were incident patients with a diagnos

266 Inclusion criteria were liver function tests 2.5 times t

267 Inclusion criteria were met by 105 269 individuals in th

268 The inclusion criteria were met by 22 prospective studies ex

269 Inclusion criteria were met by 32,531 observations of ca

270 Inclusion criteria were NMO according to Wingerchuk's 20

271 Inclusion criteria were observational or randomized stud

272 Inclusion criteria were observational studies on acute c

273 Other main inclusion criteria were palpable splenomegaly (>/=5 cm b

274 Inclusion criteria were pathology-confirmed Castleman's

275 Inclusion criteria were patients who had HCC with tumor

276 Main inclusion criteria were PM hemorrhage at CT per van Gijn

277 Inclusion criteria were positive Ebola virus reverse tra

278 Key inclusion criteria were presence of CRAB (C=calcium elev

279 Study Selection: Inclusion criteria were prospective, randomized, neoadju

280 Inclusion criteria were PTSD after military deployment a

281 Inclusion criteria were qualitative research articles pu

282 Inclusion criteria were randomized clinical trial, patie

283 Papers meeting the inclusion criteria were retrieved and full texts were fu

284 Articles that potentially met inclusion criteria were screened by two investigators.

285 Inclusion criteria were single voxel 1H-MRS studies repo

286 Inclusion criteria were stroke-specialist confirmed tran

287 Inclusion criteria were studies of at least 10 patients,

288 Inclusion criteria were studies of subjects with biopsy-

289 ors, 64 patients were enrolled and analyzed; inclusion criteria were unresectable IIIA/IIIB histologi

290 Inclusion criteria were volume optical coherence tomogra

291 Inclusion criteria were women between 25-45 years (n = 4

292 The inclusion criteria were: 1) endoscopic findings of GU an

293 Inclusion criteria were: 1) randomised controlled trial

294 thousand fifty-five patients, who satisfied inclusion criteria, were included in the final analysis.

295 Healthy volunteers meeting these inclusion criteria who were not e-cigarette users were e

296 al of 165 eyes of 110 patients fulfilled the inclusion criteria with a mean follow-up period of 109.2

297 A total of 36177 patients met the inclusion criteria, with 29068 (80.3%) receiving minor s

298 We identified 298 individuals meeting the inclusion criteria, with 816 usable MRI scans (spanning

299 studies (217 patients with cholera) met the inclusion criteria, with an average two-dose efficacy of

300 relevance of citations was assessed based on inclusion criteria, with full texts retrieved as require